Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 13, Issue 6, Pages 419-431
Publisher
Springer Nature
Online
2014-05-16
DOI
10.1038/nrd4309
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Model-based drug discovery: implementation and impact
- (2013) Sandra A.G. Visser et al. DRUG DISCOVERY TODAY
- Does size matter in R&D productivity? If not, what does?
- (2013) Michael Ringel et al. NATURE REVIEWS DRUG DISCOVERY
- Phase II and Phase III attrition rates 2011–2012
- (2013) John Arrowsmith et al. NATURE REVIEWS DRUG DISCOVERY
- Genomic responses in mouse models poorly mimic human inflammatory diseases
- (2013) Junhee Seok et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients
- (2012) William W. Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
- (2012) Ian D Pavord et al. LANCET
- Diagnosing the decline in pharmaceutical R&D efficiency
- (2012) Jack W. Scannell et al. NATURE REVIEWS DRUG DISCOVERY
- Drug-mediated toxicity: illuminating the ‘bad’ in the test tube by means of cellular assays?
- (2012) Tewes Tralau et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial
- (2012) Dona L Fleishaker et al. ARTHRITIS RESEARCH & THERAPY
- Quantitative pharmacological analysis of antagonist binding kinetics at CRF1 receptors in vitro and in vivo
- (2011) Simeon J Ramsey et al. BRITISH JOURNAL OF PHARMACOLOGY
- A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma
- (2011) N. Barnes et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
- (2011) Paul Morgan et al. DRUG DISCOVERY TODAY
- Pathophysiology of asthma: What has our current understanding taught us about new therapeutic approaches?
- (2011) Stephen T. Holgate JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The productivity crisis in pharmaceutical R&D
- (2011) Fabio Pammolli et al. NATURE REVIEWS DRUG DISCOVERY
- From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
- (2011) Bita Moghaddam et al. NEUROPSYCHOPHARMACOLOGY
- Lebrikizumab Treatment in Adults with Asthma
- (2011) Jonathan Corren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Market withdrawal of new molecular entities approved in the United States from 1980 to 2009
- (2011) Zaina P. Qureshi et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Effect on perfusion chamber thrombus size in patients with atrial fibrillation during anticoagulant treatment with oral direct thrombin inhibitors, AZD0837 or ximelagatran, or with vitamin K antagonists
- (2011) Michael Wolzt et al. THROMBOSIS RESEARCH
- In-vitro assessment of platelet function
- (2011) Susanne M. Picker TRANSFUSION AND APHERESIS SCIENCE
- CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial
- (2010) A. W. R. van Kuijk et al. ANNALS OF THE RHEUMATIC DISEASES
- Preclinical and clinical investigation of a CCR5 antagonist, AZD5672, in patients with rheumatoid arthritis receiving methotrexate
- (2010) Daniëlle M. Gerlag et al. ARTHRITIS AND RHEUMATISM
- The translatability of animal models for clinical development: biomarkers and disease models
- (2010) Alexandra Wendler et al. CURRENT OPINION IN PHARMACOLOGY
- Of Mice and Humans: Are They the Same?--Implications in Cancer Translational Research
- (2010) M. de Jong et al. JOURNAL OF NUCLEAR MEDICINE
- Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist
- (2010) F. G. Gervais et al. MOLECULAR PHARMACOLOGY
- The benefits and limitations of animal models for translational research in neurodegenerative diseases
- (2010) Mathias Jucker NATURE MEDICINE
- Neuropsychiatric adverse effects signal the end of the line for rimonabant
- (2010) Alexandra King Nature Reviews Cardiology
- Safety and tolerability of an immediate-release formulation of the oral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolism in patients with atrial fibrillation
- (2010) Lars Rasmussen et al. THROMBOSIS AND HAEMOSTASIS
- Evaluation of AR-H067637, the active metabolite of the new direct thrombin inhibitor AZD0837, in models of venous and arterial thrombosis and bleeding in anaesthetised rats
- (2010) Susanne Pehrsson et al. THROMBOSIS AND HAEMOSTASIS
- Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
- (2009) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- A prostaglandin D2receptor antagonist modifies experimental asthma in sheep
- (2009) M. Shichijo et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists
- (2009) G. Y.H. Lip et al. EUROPEAN HEART JOURNAL
- Assessing the translatability of drug projects: what needs to be scored to predict success?
- (2009) Martin Wehling NATURE REVIEWS DRUG DISCOVERY
- Lessons from 60 years of pharmaceutical innovation
- (2009) Bernard Munos NATURE REVIEWS DRUG DISCOVERY
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glutamate-based antidepressants: 20 years on
- (2009) Phil Skolnick et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- CRTH2 antagonism significantly ameliorates airway hyperreactivity and downregulates inflammation-induced genes in a mouse model of airway inflammation
- (2008) Nicholas W. Lukacs et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started